Denali Therapeutics Inc. (DNLI) Analyst Forecast

NASDAQ Currency in USD Disclaimer

Add to Alerts ADD TO LIST

$17.08

$0.01 (0.06%)

Last update: 02:02 PM EST

Day's range

$17.03

$17.71

Recent Analyst Forecasts and Stock Ratings

Date	Brokerage Firm	Analyst Name	Price Target	Price when Posted	Upside/Downside on Report Date	Details
01/08/2026	Morgan Stanley	Sean Laaman	$40.00	$16.95	135.99%
01/07/2026	UBS	Michael Yee	$25.00	$17.21	45.26%
12/11/2025	Wedbush	Laura Chico	$30.00	$17.61	70.36%
12/05/2025	Wedbush	Laura Chico	$31.00	$20.11	54.15%
11/17/2025	Stifel Nicolaus	Paul Mattels	$37.00	$17.67	109.39%
01/07/2025	BTIG	Thomas Shrader	$32.00	$21.18	51.09%
11/01/2024	Jefferies	Michael Yee	$45.00	$27.05	66.36%
10/14/2024	BTIG	Thomas Shrader	$35.00	$28.00	25%
09/04/2024	Bank of America Securities	Tazeen Ahmad	$29.00	$25.12	15.45%
09/03/2024	B.Riley Financial	Marank Mamtani	$33.00	$25.12	31.37%
09/03/2024	Goldman Sachs	Salveen Richter	$46.00	$25.12	83.12%
09/03/2024	Stifel Nicolaus	Paul Mattels	$22.00	$25.12	-12.42%
08/04/2021	Goldman Sachs	Salveen Richter	$112.00	$52.93	111.6%
05/17/2021	UBS	Esther Rajavelu	$70.00	$55.51	26.1%

Denali Therapeutics Inc. FAQ's

Denali Therapeutics Inc. has been rated by research analysts at Morgan Stanley, UBS, Wedbush, Stifel Nicolaus, BTIG, Jefferies in the past 90 days.